Trial protocols are available at the AIDS Clinical Trials Information Service (ACTIS). Call 800-TRIALS-A, or visit the ACTIS Web site at www.actis.org.
A phase III, double-blind, randomized trial to determine the efficacy of bivalent AIDSVAX B/B vaccine in adults at risk of sexually transmitted HIV infection. Study sites include:
A phase I, 68-week cohort trial of the C4-V3 vaccine alone and with IL-12 in HIV positive subjects with maximal suppression of HIV replication and CD4 cell counts greater than 400 cells/mm³. This trial is being conducted in Galveston (409-772-0361). (ACTG A5049)
A 12-month, phase I trial to compare the safety and immunogenicity of three live recombinant canarypox ALVAC HIV vaccines in HIV negative subjects. Study sites include:
A phase I, double-blind, dose-ranging trial of the ALVAC vCP205 vaccine alone or boosted with a clade B oligomeric gp160 vaccine in HIV negative subjects. This study is being conducted in Washington, DC (800-882-3105). (RV124)
A phase I/II, 104-week study to evaluate the safety and immunogenicity of ALVAC HIV vaccines alone and with AIDSVAX B/E gp120 vaccine in infants of indeterminate HIV serostatus born to HIV positive women. Study sites include:
991210
BE991224
Copyright © 1999 - San Francisco AIDS Foundation. Reproduced by permission. Reproduction of this article (other than one copy for personal reference) must be cleared through BETA: PO Box 426182, San Francisco, CA 94142-6182. Tel: 415 487 8060 Fax: 415 487 8069 URL: http://www.sfaf.org/beta E-mail: beta@sfaf.org
ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2000. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content.